Oracle Customer Spotlight Series
Thursday, April 22, 2021
It's not easy to detect clinically significant coronary artery disease when many other conditions—from reflux to pulled rib muscles—display the same symptoms. Today, ER physicians order an expensive battery of tests that can take hours or days to provide results. The cofounders of HEARTio have a better idea. They’re using data from electrocardiograms (ECG) to develop an inexpensive, cloud-based tool that uses AI and learning algorithms to help doctors quickly identify cardiac disease, assess risk, and make admission decisions. To develop their solution, they leaned heavily on Oracle Cloud Infrastructure.
Our solution requires number crunching of millions and millions of data points. On our local computer, a single experiment could take months or weeks of time…With OCI, we can have eight different experiments running at once. We can really speed up the entire process and uncover what works much more quickly than we would otherwise.
Utkars Jain CEO and Cofounder, HEARTio
HEARTio’s product has been designated a ‘breakthrough device’ by the U.S. Food and Drug Administration—a distinction given to a small number of devices that deliver truly novel ways to save lives. Given that seven million people visit ER rooms in the US for chest pain annually, the potential to do good is massive.
Join the HEARTio CEO and cofounder to hear how Oracle Cloud Infrastructure is providing the scalability, reliability, and processing power to develop a life-saving tool.
HEARTio is a member of Oracle for Startups, Oracle's program to support startups and innovators across the globe.
Utkars was born in India, and moved to the US when he was 2. Utkars is currently pursuing his Ph.D in Bioengineering at the University of Pittsburgh. His fields of interest include machine learning and artificial neural networks. Recently, Utkars has been applying these fields to medical data in novel ways hoping to create new methods for diagnosing patients. He has undergraduate degrees in Applied Mathematics and Neuroscience from the University of Pittsburgh. He is currently the CEO and Cofounder of HEARTio.